We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Clinicians Exploit Motion-Capture Imaging Technology

By LabMedica International staff writers
Posted on 07 Oct 2010
The imaginative techniques of video-game makers are helping clinicians exploit the abundance of data from imaging technology. More...
Advancements in translating scanned images into digital models to generate three-dimensional (3D) renderings--are yielding motion-capture techniques that convert data into virtual patients.

Such research is being performed at a few dedicated 3D imaging labs worldwide, such as the Hadassah Medical Center at Ein Kerem Hospital (Jerusalem, Israel). The lab provides researchers a degree of focus not possible for the busy computed tomography (CT) imaging technicians and radiologists at most hospitals, according to Dr. Jacob Sosna, head of the CT unit in the Hadassah-Hebrew University Medical Center's radiology department and director of its research and imaging laboratories. In-depth image postprocessing can yield new applications and techniques for use on patient scans, he added.

The Medical Center's lab is comprised of a medium-sized room with four workstations. Dr. Sosna noted that one of the lab's strengths is its close links to academia and industry, in addition to the medical center. He also reported that similar to motion capture, CT scanning is the product of a medical/entertainment industry collaboration. "The Beatles recorded with EMI [Electrical & Musical Industries], which was an industrial research company as well as a record label,” said Dr. Sosna, in Hadassah magazine. "The Beatles' massive success paid for EMI research that produced the CAT scanner.”

Related Links:

Hadassah Medical Center at Ein Kerem Hospital




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.